The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers. Cooperative group research has been instrumental in establishing innovative treatments that improve outcomes and quality of life. Despite these successes, the Cooperative Group Program has faced a number of challenges that threaten its effectiveness.
To address this problem, the National Cancer Policy Forum (NCPF) convened a workshop titled "Multi-Center Phase III Clinical Trials and NCI Cooperative Groups" in Washington, DC, on July 1-2, 2008. The purpose of the workshop was to outline the challenges that the public clinical cancer research enterprise faces, and to identify possible solutions to these challenges.
Table of Contents
|Session 1A: Organization of the NCI Clinical Trials System||5-26|
|Session 1B: Lessons from Non-Cooperative Group Multi-Center Clinical Trials||27-40|
|Session 2: Barriers to Patient Recruitment and Physician Participation||41-64|
|Session 3: Data Collection Standards and Monitoring||65-74|
|Session 4: Costs of Cooperative Group Clinical Trials||75-90|
|Summary and Wrap-Up||91-96|
|Abbreviations and Acronyms||103-104|
|Appendix A: Workshop Agenda||111-116|
|Appendix B: Workshop Speakers||117-118|
|Appendix C: Letter from John Niederhuber, Director of the National Cancer Institute, to Members of the National Cancer Policy Forum||119-122|
The National Academies Press and the Transportation Research Board have partnered with Copyright Clearance Center to offer a variety of options for reusing our content. You may request permission to:
For most Academic and Educational uses no royalties will be charged although you are required to obtain a license and comply with the license terms and conditions.
For information on how to request permission to translate our work and for any other rights related query please click here.
For questions about using the Copyright.com service, please contact:
Copyright Clearance Center
22 Rosewood Drive
Danvers, MA 01923
Tel (toll free): 855/239-3415 (select option 1)
Loading stats for Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary...